Belief BioMed ("BBM") and Grand Life Sciences Group Co., Ltd. ("Grand Life Sciences") today announced an exclusive collaboration agreement. Under the agreement, Belief BioMed will grant Grand Life ...
Researchers plan to begin the first patient trial in 2027 thanks to promising preclinical results from a gene therapy ...
Discover how to turn hand-drawn sketches into fully functional apps using Claude Code. This guide covers the AI workflow for converting design concepts into code ...
Eli Lilly and Regeneron are leading the push to treat congenital deafness with gene therapies, seeking a piece of a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results